Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Osteoporosis International
Published in: Osteoporosis International 3/2021

01-03-2021 | Osteoporosis | Obituary

In memory of Harry K Genant

Authors: C. Cooper, P. Halbout, B. Dawson-Hughes, N.C. Harvey, J.A. Kanis, J.-Y. Reginster, R. Rizzoli, on behalf of the International Osteoporosis Foundation

Published in: Osteoporosis International | Issue 3/2021

Login to get access

Excerpt

The International Osteoporosis Foundation (IOF) is deeply saddened to learn that Professor Harry K. Genant passed away on January 14, 2021, at the age of 78. With his passing, the bone field has lost not just a brilliant scientist but a much-loved friend, esteemed colleague, and important mentor to many in the bone community. …
Metadata
Title
In memory of Harry K Genant
Authors
C. Cooper
P. Halbout
B. Dawson-Hughes
N.C. Harvey
J.A. Kanis
J.-Y. Reginster
R. Rizzoli
on behalf of the International Osteoporosis Foundation
Publication date
01-03-2021
Publisher
Springer London
Published in
Osteoporosis International / Issue 3/2021
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-021-05857-y

Other articles of this Issue 3/2021

Osteoporosis International 3/2021 Go to the issue

Original Article

Five-year follow-up results of aerobic and impact training on bone mineral density in early breast cancer patients

Original Article

Defining an international cut-off of two-legged countermovement jump power for sarcopenia and dysmobility syndrome

Original Article

Sleep duration and bone health measures in older men

Original Article

Cost-effectiveness of romosozumab for the treatment of postmenopausal women with severe osteoporosis at high risk of fracture in Sweden

Original Article

Exploring thoracic kyphosis and incident fracture from vertebral morphology with high-intensity exercise in middle-aged and older men with osteopenia and osteoporosis: a secondary analysis of the LIFTMOR-M trial

Original Article

Cost-effectiveness of buffered soluble alendronate 70 mg effervescent tablet for the treatment of postmenopausal women with osteoporosis in Italy